Rhoen Klinikum AG (ETR:RHK) Given a €21.00 Price Target by Deutsche Bank AG Analysts

Rhoen Klinikum AG (ETR:RHK) has been given a €21.00 ($24.71) price objective by investment analysts at Deutsche Bank AG in a research report issued to clients and investors on Friday. The brokerage currently has a “neutral” rating on the stock.

Receive News & Ratings for Rhoen Klinikum AG Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.

A number of other brokerages have also recently weighed in on RHK. Credit Suisse Group set a €24.40 ($28.71) price target on Rhoen Klinikum AG and gave the stock a “sell” rating in a research report on Friday. Warburg Research set a €26.00 ($30.59) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Thursday. Baader Bank set a €24.00 ($28.24) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Thursday. Commerzbank Ag set a €25.00 ($29.41) price target on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Thursday. Finally, Jefferies Group LLC set a €17.60 ($20.71) price target on Rhoen Klinikum AG and gave the stock a “sell” rating in a research report on Thursday. Three equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company. Rhoen Klinikum AG presently has a consensus rating of “Hold” and a consensus target price of €23.43 ($27.56).

Rhoen Klinikum AG (ETR RHK) opened at 26.832 on Friday. The firm has a 50 day moving average price of €25.95 and a 200 day moving average price of €25.79. The stock has a market capitalization of €1.80 billion and a P/E ratio of 125.383. Rhoen Klinikum AG has a 52 week low of €22.91 and a 52 week high of €27.51.

COPYRIGHT VIOLATION NOTICE: “[[title]]” was first reported by [[site]] and is owned by of [[site]]. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at [[permalink]].

Rhoen Klinikum AG Company Profile